{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:55:08Z","timestamp":1790013308475,"version":"4.0.1"},"reference-count":151,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaad.2021.12.062","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T01:56:32Z","timestamp":1644198992000},"page":"733-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Racial and ethnic health disparities in dermatology in the United States. Part 2: Disease-specific epidemiology, characteristics, management, and outcomes"],"prefix":"10.1016","volume":"87","author":[{"given":"Kimberly","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaad.2021.12.062_bib1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib2","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2020.2571","article-title":"Association of age, sex, race, and geographic region with variation of the ratio of basal cell to cutaneous squamous cell carcinomas in the\u00a0United States","volume":"156","author":"Lukowiak","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"21","key":"10.1016\/j.jaad.2021.12.062_bib3","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMra044151","article-title":"Basal-cell carcinoma","volume":"353","author":"Rubin","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/DSS.0000000000001547","article-title":"Review of nonmelanoma skin cancer in African Americans, Hispanics, and Asians","volume":"44","author":"Higgins","year":"2018","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaad.2005.08.063","article-title":"Skin cancer in skin of color","volume":"55","author":"Gloster","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1067\/mjd.2002.124083","article-title":"Squamous cell carcinoma of the legs in African Americans","volume":"47","author":"McCall","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaad.2009.11.019","article-title":"Squamous cell carcinomas of the lower limbs in African American women","volume":"65","author":"Woolery-Lloyd","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib8","first-page":"313","article-title":"Multiple squamous cell carcinomas in lesions of discoid lupus erythematosus","volume":"36","author":"Garrett","year":"1985","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jdcr.2015.03.009","article-title":"Poorly differentiated squamous cell carcinoma arising within a lesion of discoid lupus erythematosus in an African-American woman","volume":"1","author":"Gamble","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/RHU.0b013e3182051928","article-title":"Squamous cell carcinomas arising in discoid lupus erythematosus scars: unusual occurrence in an African-American and in a sun-protected area","volume":"17","author":"Alsanafi","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib11","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"10.1016\/j.jaad.2021.12.062_bib12","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.6004\/jnccn.2014.0172","article-title":"Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?","volume":"12","author":"Gumaste","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaad.2018.10.045","article-title":"Merkel cell carcinoma incidence, trends, and survival rates among adults aged \u226550 years from United States Cancer Statistics","volume":"80","author":"Freeman","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2021.12.062_bib14","first-page":"849767","article-title":"Giant Merkel cell carcinoma masquerading as a benign cyst on the buttock of an African American man","volume":"2011","author":"Perman","year":"2011","journal-title":"Case Rep Oncol Med"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1346-8138.2000.tb02190.x","article-title":"Postoperative hyponatremia in a patient with ACTH-producing Merkel cell carcinoma","volume":"27","author":"Anzai","year":"2000","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib16","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1111\/bjd.15357","article-title":"Association of patient demographic characteristics with dermatofibrosarcoma protuberans tumour size at diagnosis in the U.S. National Cancer Database","volume":"177","author":"Trofymenko","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaad.2006.09.006","article-title":"Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002","volume":"56","author":"Criscione","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2021.12.062_bib18","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/DSS.0000000000000300","article-title":"Incidence and survival of primary dermatofibrosarcoma protuberans in the United States","volume":"42","author":"Kreicher","year":"2016","journal-title":"Dermatol Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.11.038","article-title":"Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public","volume":"70","author":"Agbai","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib20","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.jaad.2015.12.015","article-title":"Dermoscopy of dermatofibrosarcoma protuberans on black skin","volume":"74","author":"Piccolo","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2008.10.031","article-title":"Cutaneous T-cell lymphoma in skin of color","volume":"60","author":"Hinds","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/DER.0000000000000323","article-title":"Predictors of hospitalization, length of stay, and costs of care among adult and pediatric inpatients with atopic dermatitis in the United States","volume":"29","author":"Narla","year":"2018","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jaci.2013.08.031","article-title":"Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study","volume":"132","author":"Silverberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.det.2011.08.002","article-title":"Dermatologic health disparities","volume":"30","author":"Buster","year":"2012","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/exd.13514","article-title":"Atopic dermatitis in diverse racial and ethnic groups\u2014variations in epidemiology, genetics, clinical presentation and treatment","volume":"27","author":"Kaufman","year":"2018","journal-title":"Exp Dermatol 04"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2015.09.011","article-title":"Atopic dermatitis: age and race do matter","volume":"136","author":"Leung","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaad.2020.11.039","article-title":"Incidence of psoriasis among adults in the United States: a sex- and age-adjusted population analysis","volume":"84","author":"Burshtein","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40257-017-0332-7","article-title":"Psoriasis in skin of color: insights into the epidemiology, clinical presentation, genetics, quality-of-life impact, and treatment of psoriasis in non-white racial\/ethnic groups","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib32","first-page":"16","article-title":"Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances","volume":"7","author":"Alexis","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib33","first-page":"1","article-title":"A cross-sectional study of the distribution of psoriasis subtypes in different ethno-racial groups","volume":"24","author":"Yan","year":"2018","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib35","article-title":"Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review","volume":"23","author":"Vaidya","year":"2017","journal-title":"Dermatol Online J"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2340\/00015555-2176","article-title":"Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis","volume":"95","author":"Vlassova","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib37","first-page":"e139","article-title":"Investigating race and gender in age at onset of hidradenitis suppurativa","volume":"34","author":"Morss","year":"2020","journal-title":"J Eur Acad Dermatol Venereol. March"},{"issue":"9","key":"10.1016\/j.jaad.2021.12.062_bib38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1468-3083.2010.03919.x","article-title":"Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women","volume":"25","author":"Perkins","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib39","first-page":"24","article-title":"A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.12.062_bib40","article-title":"Rosacea in skin of color: not a rare diagnosis","volume":"20","author":"Al-Dabagh","year":"2014","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib41","first-page":"60","article-title":"Rosacea in patients with skin of color: uncommon but not rare","volume":"86","author":"Alexis","year":"2010","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib42","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.jaad.2018.08.049","article-title":"Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience","volume":"80","author":"Alexis","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib43","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2013.3064","article-title":"Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011","volume":"149","author":"Wysong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib44","doi-asserted-by":"crossref","first-page":"122.e9","DOI":"10.1016\/j.urolonc.2015.10.001","article-title":"Racial and economic disparities in the treatment of penile squamous cell carcinoma: results from the National Cancer Database","volume":"34","author":"Sharma","year":"2016","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.jaad.2021.12.062_bib45","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hed.21125","article-title":"Barriers to early detection and treatment of head and neck squamous cell carcinoma in African American men","volume":"31","author":"Carroll","year":"2009","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(81)70113-0","article-title":"Cancer of the skin in blacks. I. A review of 163 Black patients with cutaneous squamous cell carcinoma","volume":"5","author":"Mora","year":"1981","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib47","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.jaad.2021.12.062_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0190-9622(88)70042-0","article-title":"Cancer of the skin in Blacks. V. A review of 175 Black patients with squamous cell carcinoma of the penis","volume":"18","author":"Hubbell","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib49","doi-asserted-by":"crossref","first-page":"688.e11","DOI":"10.1016\/j.urolonc.2020.03.003","article-title":"Racial\/ethnic disparities in penile squamous cell carcinoma incidences, clinical characteristics, and outcomes: a population-based study, 2004-2016","volume":"38","author":"Huang","year":"2020","journal-title":"Urol Oncol 08"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib50","first-page":"156","article-title":"Squamous cell carcinoma of the skin in Black patients with discoid lupus erythematosus","volume":"14","author":"Caruso","year":"1987","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.12.062_bib51","first-page":"5257","article-title":"Skin cancer concerns in people of color: risk factors and prevention","volume":"17","author":"Gupta","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1470-2045(21)00126-1","article-title":"Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial","volume":"22","author":"Stratigos","year":"2021","journal-title":"Lancet Oncol. June"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib54","first-page":"170","article-title":"Skin cancer in skin of color","volume":"21","author":"Bradford","year":"2009","journal-title":"Dermatol Nurs"},{"issue":"15","key":"10.1016\/j.jaad.2021.12.062_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006258","article-title":"Malignant melanoma in African-Americans: a population-based clinical outcomes study involving 1106 African-American patients from the surveillance, epidemiology, and end result (SEER) database (1988-2011)","volume":"96","author":"Mahendraraj","year":"2017","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(03)02091-7","article-title":"Advanced presentation of melanoma in African Americans","volume":"50","author":"Byrd","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"17","key":"10.1016\/j.jaad.2021.12.062_bib57","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","article-title":"Ethnic differences among patients with cutaneous melanoma","volume":"166","author":"Cormier","year":"2006","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib58","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2017.11.019","article-title":"Racial disparities and insurance status: an epidemiological analysis of Ohio melanoma patients","volume":"78","author":"Kooistra","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib59","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaad.2020.08.097","article-title":"The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (1975-2016)","volume":"84","author":"Qian","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib60","first-page":"516","article-title":"Dermatologist practices during total body skin examinations: a survey study","volume":"17","author":"Rieder","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5826\/dpc.0902a09","article-title":"Total body skin examination practices: a survey study amongst dermatologists at high-risk skin cancer clinics","volume":"9","author":"Bajaj","year":"2019","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib63","first-page":"420","article-title":"Skin cancer epidemiology and sun protection behaviors among Native Americans","volume":"18","author":"Maarouf","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib64","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jaad.2020.04.137","article-title":"Racial and ethnic disparities in melanoma awareness: a cross-sectional survey","volume":"83","author":"Sanchez","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaad.2017.07.050","article-title":"Socioeconomic and geographic barriers to dermatology care in urban and rural US populations","volume":"78","author":"Vaidya","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib66","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archdermatol.2011.345","article-title":"Association of increased dermatologist density with lower melanoma mortality","volume":"148","author":"Aneja","year":"2012","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib67","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jaad.2020.03.094","article-title":"Racial differences in time to treatment for melanoma","volume":"83","author":"Tripathi","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/cncr.32587","article-title":"Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States","volume":"126","author":"Abudu","year":"2020","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib69","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/jamadermatol.2017.3338","article-title":"Association of delays in surgery for melanoma with insurance type","volume":"153","author":"Adamson","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib70","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaad.2019.05.079","article-title":"Factors associated with time to surgery in melanoma: an analysis of the National Cancer Database","volume":"81","author":"Baranowski","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib71","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjsurg.2020.12.040","article-title":"Does acral lentiginous melanoma subtype account for differences in patterns of care in Black patients?","volume":"221","author":"Carter","year":"2021","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib72","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CJI.0000000000000264","article-title":"Racial and socioeconomic disparities in the delivery of immunotherapy for metastatic melanoma in the United States","volume":"42","author":"Haque","year":"2019","journal-title":"J Immunother"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jamadermatol.2016.4129","article-title":"Diversity in dermatology clinical trials: a systematic review","volume":"153","author":"Charrow","year":"2017","journal-title":"JAMA Dermatol. February"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib74","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib75","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2018.03.019","article-title":"Factors associated with advanced-stage Merkel cell carcinoma at initial diagnosis and the use of radiation therapy: results from the National Cancer Database","volume":"79","author":"Trofymenko","year":"2018","journal-title":"J Am Acad Dermatol. October"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jaad.2016.10.043","article-title":"A population-based cohort study on the association of dermatologist density and Merkel cell carcinoma survival","volume":"76","author":"Criscito","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib77","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/DSS.0000000000000910","article-title":"A comparison of mohs micrographic surgery and wide local excision for treatment of dermatofibrosarcoma protuberans with long-term follow-up: the Mayo Clinic experience","volume":"43","author":"Lowe","year":"2017","journal-title":"Dermatol Surg"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib78","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib79","first-page":"633","article-title":"Racial in the clinical presentation and prognosis of patients with mycosis fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J Natl Med Assoc"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","article-title":"Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and S\u00e9zary syndrome in the southeastern United States: a single-institution cohort","volume":"72","author":"Desai","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2008.09.063","article-title":"Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides","volume":"60","author":"Sun","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib82","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jaad.2012.11.021","article-title":"Racial differences in mycosis fungoides: a retrospective study with a focus on eosinophilia","volume":"68","author":"Zampella","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib83","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0733-8635(05)70168-6","article-title":"Issues in dermatologic health care delivery in minority populations","volume":"18","author":"McMichael","year":"2000","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mjd.2002.120911","article-title":"Narrowband UVB phototherapy for early-stage mycosis fungoides","volume":"47","author":"Gathers","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib85","first-page":"18","article-title":"Mycosis fungoides with depigmentation secondary to treatment","volume":"13","author":"Firoz","year":"2007","journal-title":"Dermatol Online J"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e31825494d3","article-title":"Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex","volume":"36","author":"Hinds","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib87","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/09546634.2014.946381","article-title":"Racial differences in the use of extracorporeal photopheresis for mycosis fungoides","volume":"26","author":"Agi","year":"2015","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib89","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaad.2016.02.717","article-title":"Racial differences in survival of patients with Sezary syndrome in the United States: a population-based study of 204 cases","volume":"74","author":"Jang","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib90","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib91","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaip.2017.10.005","article-title":"Phenotypical differences of childhood- and adult-onset atopic dermatitis","volume":"6","author":"Silverberg","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib92","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jid.2018.10.029","article-title":"Racial\/ethnic differences in incidence and persistence of childhood atopic dermatitis","volume":"139","author":"Kim","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib93","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2017.05.031","article-title":"Patterns and predictors of atopic dermatitis disease control past childhood: an observational cohort study","volume":"141","author":"Abuabara","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib94","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaci.2019.06.044","article-title":"Genetic ancestry does not explain increased atopic dermatitis susceptibility or worse disease control among African American subjects in 2 large US cohorts","volume":"145","author":"Abuabara","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib95","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13671-014-0097-7","article-title":"Racial and ethnic disparities in atopic dermatitis","volume":"4","author":"Silverberg","year":"2015","journal-title":"Curr Dermatol Rep"},{"issue":"360","key":"10.1016\/j.jaad.2021.12.062_bib96","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017-2018","volume":"360","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jaad.2021.12.062_bib97","author":"Parker"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib98","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.anai.2018.11.015","article-title":"Racial differences in atopic dermatitis","volume":"122","author":"Brunner","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib99","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/1346-8138.14116","article-title":"Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis","volume":"45","author":"Wei","year":"2018","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib100","first-page":"650","article-title":"Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study","volume":"112","author":"Bell","year":"2020","journal-title":"J Natl Med Assoc"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib101","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamadermatol.2014.1674","article-title":"Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States","volume":"150","author":"Bhattacharya","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib102","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1525-1470.2012.01797.x","article-title":"Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009","volume":"29","author":"Hirano","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib103","first-page":"804","article-title":"Efficacy of Dupilumab in different racial subgroups of adults with moderate-to-severe atopic dermatitis in three randomized, placebo-controlled Phase 3 trials","volume":"18","author":"Alexis","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"10246","key":"10.1016\/j.jaad.2021.12.062_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(20)30732-7","article-title":"Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"396","author":"Simpson","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40257-019-00450-w","article-title":"Efficacy and safety of Crisaborole ointment, 2%, for the treatment of mild-to-moderate atopic dermatitis across racial and ethnic groups","volume":"20","author":"Callender","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/DER.0000000000000418","article-title":"Atopic dermatitis and hospitalization for mental health disorders in the United States","volume":"30","author":"Hsu","year":"2019","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib107","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1073191115599639","article-title":"Measurement equivalence of the K6 scale: the effects of race\/ethnicity and language","volume":"23","author":"Kim","year":"2016","journal-title":"Assessment. 12"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib108","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib109","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1087-0024.2003.09102.x","article-title":"Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction","volume":"9","author":"Stern","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaad.2017.07.052","article-title":"Health care utilization for psoriasis in the United States differs by race: an analysis of the 2001-2013 Medical Expenditure Panel Surveys","volume":"78","author":"Fischer","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib112","first-page":"866","article-title":"A retrospective study to investigate racial and ethnic variations in the treatment of psoriasis with etanercept","volume":"10","author":"Shah","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib113","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaad.2017.02.042","article-title":"Ethnicity affects the presenting severity of psoriasis","volume":"77","author":"Abrouk","year":"2017","journal-title":"J Am Acad Dermatol 07"},{"issue":"12","key":"10.1016\/j.jaad.2021.12.062_bib114","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/jid.2015.296","article-title":"Psoriasis in the US medicare population: prevalence, treatment, and factors associated with biologic use","volume":"135","author":"Takeshita","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/bjd.19876","article-title":"Biologics utilization for psoriasis is lower in Black compared to white patients","volume":"185","author":"Hodges","year":"2021","journal-title":"Br J Dermatol. February"},{"issue":"10","key":"10.1016\/j.jaad.2021.12.062_bib116","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","article-title":"Psoriasis and psoriatic arthritis in African-American patients\u2014the need to measure disease burden","volume":"34","author":"Kerr","year":"2015","journal-title":"Clin Rheumatol. October"},{"issue":"8","key":"10.1016\/j.jaad.2021.12.062_bib117","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.jid.2018.12.032","article-title":"Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment","volume":"139","author":"Takeshita","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2021.12.062_bib118","first-page":"1","article-title":"Language proficiency and biologics access: a population study of psoriasis patients in the United States","author":"Chat","year":"2020","journal-title":"J Dermatolog Treat. September"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib119","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jamadermatol.2018.5462","article-title":"Association of atherosclerosis prevalence with age, race, and traditional risk factors in patients with psoriasis","volume":"155","author":"Arnold","year":"2019","journal-title":"JAMA Dermatol 05"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000504911","article-title":"Race and ethnicity gaps in global hidradenitis suppurativa clinical trials","volume":"237","author":"Price","year":"2021","journal-title":"Dermatology"},{"issue":"12","key":"10.1016\/j.jaad.2021.12.062_bib121","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/aje\/kwu078","article-title":"Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States","volume":"179","author":"McMillan","year":"2014","journal-title":"Am J Epidemiol. June"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib122","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000431037","article-title":"Hidradenitis suppurativa management in the United States: an analysis of the National ambulatory medical care survey and MarketScan Medicaid databases","volume":"1","author":"Davis","year":"2015","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib123","first-page":"44","article-title":"Higher risk of care for\u00a0hidradenitis suppurativa in African American and non-Hispanic patients in the United States","volume":"109","author":"Udechukwu","year":"2017","journal-title":"J Natl Med Assoc"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib124","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1203475418803077","article-title":"African American patients with hidradenitis suppurativa have significant health care disparities: a retrospective study","volume":"23","author":"Soliman","year":"2019","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib125","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/000313481608200423","article-title":"Recalcitrant hidradenitis suppurativa: an investigation of demographics, surgical management, bacterial isolates, pharmacologic intervention, and patient-reported health outcomes","volume":"82","author":"Thomas","year":"2016","journal-title":"Am Surg"},{"key":"10.1016\/j.jaad.2021.12.062_bib126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdin.2021.01.007","article-title":"Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: a retrospective analysis of 2 U.S. cohorts","volume":"3","author":"Kilgour","year":"2021","journal-title":"JAAD Int"},{"issue":"9","key":"10.1016\/j.jaad.2021.12.062_bib127","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamadermatol.2018.2117","article-title":"Association of low socioeconomic status with hidradenitis suppurativa in the United States","volume":"154","author":"Wertenteil","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with hidradenitis suppurativa","volume":"155","author":"Reddy","year":"2019","journal-title":"JAMA Dermatol 07"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib129","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1159\/000486741","article-title":"Hidradenitis suppurativa: disease burden and etiology in skin of color","volume":"233","author":"Lee","year":"2017","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bjd.15939","article-title":"Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib131","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/ijd.14313","article-title":"Rethinking the female predominance in hidradenitis suppurativa","volume":"58","author":"Choi","year":"2019","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib132","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1111\/jdv.15507","article-title":"Korean gender differences in hidradenitis suppuratva: nature or nurture?","volume":"33","author":"Happle","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.jaad.2021.12.062_bib133","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1038\/jid.2014.220","article-title":"Ethnicity and hidradenitis suppurativa","volume":"134","author":"Reeder","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.12.062_bib134","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jaad.2020.05.090","article-title":"New-onset depression among children, adolescents, and adults with hidradenitis suppurativa","volume":"83","author":"Wright","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib135","first-page":"548","article-title":"Major depressive disorder in the African American population","volume":"103","author":"Bailey","year":"2011","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jaad.2021.12.062_bib136","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/NDT.S128584","article-title":"Racial and ethnic differences in depression: current perspectives","volume":"15","author":"Bailey","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib137","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1111\/ijd.13481","article-title":"Disparities in access to a dermatologist for acne care in the United States","volume":"56","author":"Patel","year":"2017","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib138","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/09546634.2017.1371836","article-title":"Racial disparities in the management of acne: evidence from the National Ambulatory Medical Care Survey, 2005-2014","volume":"29","author":"Rogers","year":"2018","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib139","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2019.4818","article-title":"Association of race\/ethnicity and sex with differences in health care use and treatment for acne","volume":"156","author":"Barbieri","year":"2020","journal-title":"JAMA Dermatol 03"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2018.09.037","article-title":"Acne disparities in Native Americans","volume":"85","author":"Zullo","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib141","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1067\/S0190-9622(03)01584-6","article-title":"Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States?","volume":"49","author":"Fleischer","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210445","article-title":"Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era","volume":"14","author":"Charrow","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.jaad.2021.12.062_bib143","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jaad.2020.11.055","article-title":"Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients","volume":"85","author":"Shah","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.12.062_bib144","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jaad.2018.05.038","article-title":"Readability of iPledge program patient education materials","volume":"79","author":"Howard","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2021.12.062_bib145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/JDN.0000000000000129","article-title":"Acne-related quality of life among female adults of different races\/ethnicities","volume":"7","author":"Gorelick","year":"2015","journal-title":"J Dermatol Nurses Assoc"},{"issue":"3S","key":"10.1016\/j.jaad.2021.12.062_bib146","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.12788\/j.sder.2018.027","article-title":"Treating acne\u00a0in\u00a0patients with skin of color","volume":"37","author":"Alexis","year":"2018","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.jaad.2021.12.062_bib147","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40257-013-0049-1","article-title":"Acne in patients with skin of color: practical management","volume":"15","author":"Yin","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.12.062_bib148","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1067\/mjd.2002.120791","article-title":"Acne vulgaris in skin of color","volume":"46","author":"Taylor","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.12.062_bib149","first-page":"1201","article-title":"Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser","volume":"30","author":"Alster","year":"2004","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.jaad.2021.12.062_bib150","first-page":"608","article-title":"Patient-focused solutions in rosacea management: treatment challenges in special patient groups","volume":"18","author":"Cices","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.12.062_bib151","first-page":"1219","article-title":"Effectiveness and safety of once-daily doxycycline capsules as monotherapy in patients with rosacea: an analysis by Fitzpatrick skin type","volume":"11","author":"Alexis","year":"2012","journal-title":"J Drugs Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:04:54Z","timestamp":1759273494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":151,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0190962222001955"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.12.062","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial and ethnic health disparities in dermatology in the United States. Part 2: Disease-specific epidemiology, characteristics, management, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.12.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.12.061","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(22)02563-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}